Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Broadcom

Gilead Sciences

Southern Company

AT&T

New month... new stock considerations. I can't believe that October is already here... the final quarter of 2020. Seeing how fast time blows by simply reminds me to stay invested no matter how crazy the market seems to be.

October 2020 Stock Considerations

British American Tobacco

Charter Communications

Diageo

Alphabet

Imperial Brands PLC

L'Oreal SA

Marriott

PayPal

Zoetis

We highlight the most attractive opportunities this month, by reviewing notable price moves and rating changes in our research.

Librarian Capital's Monthly Top Buys And Price Moves - September 2020

AbbVie

CVS Health

ONEOK

Takeda Pharmaceutical

Chasing high yields alone will ruin an income investor’s returns, so we look at these picks that offer a balance of stability and dividend income growth. The post 7 Dividend Stocks Perfect for a Retiree’s Portfolio appeared first on InvestorPlace.

7 Dividend Stocks Perfect for a Retiree’s Portfolio

We believe there may be a good opportunity with Altria stock at the present time. MO trades at $39 currently and is in fact down 16% so far this year.

Altria: The Defensive Stock With More Than 20% Potential Gain

AAON

Archer-Daniels-Midland Company

Avangrid

Philip Morris

Although this has been the worst September for stocks in 18 years, the indices ended the last 3 trading days in the green, and chipped away at losses. For investors looking to make sense of these interesting times, our deep learning algorithms have crunched the data to give you a set of Top Buys.

Top Stocks To Buy Today As Markets Cool Off And Open Flat

Carlisle Companies

Johnson & Johnson

The 3 Best Dividend Aristocrats Retirees Can Buy With Market Volatility This High

Altria (MO) is gaining from rising popularity of low risk tobacco alternatives. However the company's smokeable unit is bearing the brunt of soft cigarette sales.

Oral Tobacco Unit Supports Altria Amid Poor Cigarette Sales

For the long term these two stocks can supercharge a dividend growth portfolio, for both income and capital appreciation.

Retirement Strategy: Not One But Two Gifts For Dividend Investors

Altria doesn't come without risks. However, the risks are more than priced in at the current share price.

Altria: Stocking Up At These Levels

General Dynamics

I added to my taxable account 27 shares at $27.89, for a total investment of $753.03 in AT&T Inc.

Recent Stock Purchase II September 2020

Bayer AG

Biogen

Bank of New York Mellon

Bristol-Myers

Cerner

GlaxoSmithKline

Intel

Merck

Roche Holding AG

Wide-Moat Stocks On Sale - The October 2020 Heat Map

Bill Gross forecasts the end of government stimulus and recommends buying Tobacco stocks.

How Bill Gross Leads You From Sovereign Debt To Tobacco

Lockheed Martin

STORE Capital

4 Dividend Growth Opportunities To Benefit From Market Decline

Turning Point Brands

Universal Corp

These are the tobacco stocks with the best value, growth, and most momentum for Q4 2020.

Top Tobacco Stocks for Q4 2020

I think the "cigarette sales are on the decline" story is very, very old and has limited relevance to investors in companies like this today.

Altria's Dividend Is Fine

MO has exhibited classic former dividend superstar behavior.

Altria: Something Is Wrong

SPDR Dow Jones Industrial Average ETF

Global Partners

iShares Russell 1000 Growth ETF

iShares Russell 2000 ETF

Medical Properties Trust

Invesco QQQ

SPDR S&P 500 ETF Trust

AT&T 5.35 % Notes 2017-01.11.66 Global

Retirement: Preservation Of Income Is Your Best Friend

Vector Group

4 Tobacco Stocks to Watch Amid Rising Popularity of RRPs

Cronos Group

Over a five-year stretch, these cannabis stocks offer a compound annual growth rate ranging between 59% and 105%.

The 3 Fastest-Growing Pot Stocks Through 2024

Atrion

Community Bank System

Community Trust Bancorp

Logitech

National Storage Affiliates Trust

Worthington Industries

7 Upcoming Dividend Increases Including This Dividend King

Amazon

Cisco Systems

Enbridge

Enterprise Products Partners

Prudential Financial

Tencent Holdings Limited

8 High-Yield Blue-Chips I'm Buying For My Retirement Portfolio During This Market Downturn

News for Altria Stock (MO)